ShareValue scores for INAF.JK: Valuation 32, Quality 8, Growth 38, Health 23.
INAF.JKIDX
Indofarma Tbk
IDR 126.00
(0.00%)
INAF.JKIDX
Indofarma Tbk
IDR 126.00(0.00%)
Loading chart...
Sentiment
Verdicts
Value:Overvalued
Quality:Weak
Growth:Weak
Health:Stressed
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
-12% to 12%
Rating
Trap Risk
Return
-12% to 12%
Valuation
32
Overvalued
Price vs Value
Quality
8
Weak
Business Strength
Growth
38
Weak
Revenue & Earnings
Health
23
Stressed
Financial Stability
Momentum
23
Bearish
Price Trend
Company Details
About
PT Indofarma Tbk, together with its subsidiaries, manufactures and sells pharmaceutical products in Indonesia and internationally. The company operates through medicine, Medical devices and Others, and Engineering Pharmaceuticals. It engages in marketing, trading and distribution of medicine and medical devices; and clinical lab. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is based in Bekasi, Indonesia. The company operates as a subsidiary of PT Bio Farma.
Market Cap$390.51B
P/E RatioN/A
Dividend YieldNone
Sector Rank#2785
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026